MicroRNAs are poised to play a big role in the future understanding and treatment of rheumatoid arthritis.
Between 400,000 and 3.1 million adults are affected by Sjögren’s syndrome, and the disease is often challenging to identify.
Sjögren’s syndrome is an inflammatory disease that can affect many different parts of the body.
The Annual Meeting will provide numerous opportunities to learn the latest clinical findings in the field and to update their knowledge in all aspects of rheumatology.
Sexual dysfunction is frequently one of the first manifestations of physical illness, but is often not inquired about on routine reviews of systems.
The ACR has published three documents intended to provide clarity and consensus on management of osteoarthritis, classification criteria for Sjögren’s syndrome, and classification criteria for polymyalgia rheumatica. The documents, which represent the most current clinical evidence, research, and expert panel input and review, can help inform clinical practice and provide clearer target populations for future research.
Diverse group of experts driving discovery about this disease
Updates on Sjogren’s syndrome, myositis, and vasculitis